Antiemetic activity of volatile oil from Mentha spicata and Mentha × piperita in chemotherapy-induced nausea and vomiting
Z Tayarani-Najaran, E Talasaz-Firoozi, R Nasiri, N Jalali, Mk Hassanzadeh, Z Tayarani-Najaran, E Talasaz-Firoozi, R Nasiri, N Jalali, Mk Hassanzadeh
Abstract
Background: This study is aimed at determining the efficacy of Mentha spicata (M. spicata) and Mentha × piperita (M. × piperita) in preventing chemotherapy-induced nausea and vomiting (CINV).
Methods: This was a randomised, double-blind clinical trial study. Prior to the study, patients were randomly assigned into four groups to receive M. spicata or M. × piperita. Statistical analysis included the χ(2) test, relative risk, and Student's t-test. Fifty courses were analysed for each group that met our eligibility criteria. The treatment and placebo groups applied essential oils of M. spicata, M. × piperita, or a placebo, while the control group continued with their previous antiemetic regimen. Patients or guardians recorded the number of emetic events, the intensity of nausea over 20 h of chemotherapy, as well as any possible adverse effects that occurred during this time.
Results: There was a significant reduction in the intensity and number of emetic events in the first 24 h with M. spicata and M. × piperita in both treatment groups (p < 0.05) when compared with the control and no adverse effects were reported. The cost of treatment was also reduced when essential oils were used.
Conclusion: M. spicata or M. × piperita essential oils are safe and effective for antiemetic treatment in patients, as well as being cost effective.
Keywords: Lamiaceae; Mentha spicata; Mentha × piperita; chemotherapy-induced nausea and vomiting (CINV); essential oils.
References
- Koeller J, Aapro M, Gralla R, et al. Antiemetic guidelines: creating a more practical treatment approach. Support Care Cancer. 2002;10:519–22. doi: 10.1007/s00520-001-0335-y.
- Lindley C, Bernard S, Fields S. Incidence, duration of chemotherapy-induced nausea, vomiting in the out patient oncology population. J Clin Oncol. 1989;7:1142–9.
- Molassiotis A, Saunders MP, Valle J, et al. A prospective observational study of chemotherapy-related nausea, vomiting in routine practice in a UK cancer centre. Support Care Cancer. 2008;16:2018. doi: 10.1007/s00520-007-0343-7.
- Edris AE. Pharmaceutical, therapeutic potentials of essential oils, their individual volatile constituents: A review. Phytother Res. 2007;214:308–23. doi: 10.1002/ptr.2072.
- Anderson LA, Gross JB. Aromatherapy with peppermint isopropyl alcohol or placebo is equally effective in relieving postoperative nausea. J Post Anesth Nurs. 2004;191:29–35.
- Tate S. Peppermint oil: a treatment for postoperative nausea. J Adv Nurs. 1997;26:543–549. doi: 10.1046/j.1365-2648.1997.t01-15-00999.x.
- Buckle J. Clinical Aromatherapy: Essential Oils in Practice. 2. Edinburg: Churchill Livingstone; 2003.
- Asao T, Mochiki E, Suzuki H, Nakamura J, Hirayama I, Morinaga N, et al. An easy method for the intraluminal administration of peppermint oil before colonoscopy, its effectiveness in reducing colonic spasm. Gastrointest Endosc. 2001;53:172–7. doi: 10.1067/mge.2000.108477.
- Leicester RJ, Hunt RH. Peppermint oil to reduce colonic spasm during endoscopy. Lancet. 1982;2:989. doi: 10.1016/S0140-6736(82)90191-X.
- McKenzie J, Gallacher M. A sweet smelling success. Nurs Times. 1989;85:48–9.
- Phillips S, Ruggier R, Hutchinson SE. Zingiber officinale ginger – an antiemetic for day case surgery. Anaesthesia. 1993;48:715–7. doi: 10.1111/j.1365-2044.1993.tb07188.x.
- Meyer K, Schwartz J, Crater D, Keyes B. Zingiber officinale ginger used to prevent 8-MOP associated nausea. Dermatol Nurs. 1995;7:242–4.
- Srivastava R, Shukla YN, Sushil K. Chemistry, pharmacology of Centella asiatica: a review. J Med Arom Plant Sci. 1997;19:1049–56.
- Krishnasamy M. In: Cancer Nursing: Care in Context. 2. Corner J, Bailey C, editors. Oxford: Blackwell Science; 2008. pp. 350–7.
Source: PubMed